Data as of Mar 07
| -1.01 / -3.83%|
The 8 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 39.50, with a high estimate of 45.00 and a low estimate of 29.00. The median estimate represents a +55.76% increase from the last price of 25.36.
The current consensus among 8 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.